
HPLC Verified
Research Grade
COA Published
Survodutide 10mg
Survodutide
GLP-1/GcgR dual agonist. 98.5% purity. 10mg vial; Phase 2 NASH and obesity trial data demonstrate hepatic fat reduction alongside adipose loss via glucagon receptor co-activation.
Price
$159.99
18 in stock
HPLC verified · third-party tested · research use only
Specifications
Survodutide — Research Overview
GLP-1/GcgR dual agonist. 98.5% purity. 10mg vial; Phase 2 NASH and obesity trial data demonstrate hepatic fat reduction alongside adipose loss via glucagon receptor co-activation.
Related Products

Semaglutide 3mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Starter 3mg vial suited to initial dose-titration research; STEP-1 trial recorded −14.9% mean body weight at 68 weeks.
$49.99
CAS 910463-68-2

Semaglutide 6mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Mid-range 6mg vial supports two-vial titration schedules; STEP-1 Phase 3 mean weight reduction −14.9% over 68 weeks.
$79.99
CAS 910463-68-2
Survodutide 10mg
$159.99

